193 related articles for article (PubMed ID: 7530490)
1. First trimester maternal serum alpha-fetoprotein in fetal trisomies.
Brizot ML; Kuhn P; Bersinger NA; Snijders RJ; Nicolaides KH
Br J Obstet Gynaecol; 1995 Jan; 102(1):31-4. PubMed ID: 7530490
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies.
Bersinger NA; Brizot ML; Johnson A; Snijders RJ; Abbott J; Schneider H; Nicolaides KH
Br J Obstet Gynaecol; 1994 Nov; 101(11):970-4. PubMed ID: 7528054
[TBL] [Abstract][Full Text] [Related]
5. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
Nicolaides KH; Brizot ML; Snijders RJ
Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
[TBL] [Abstract][Full Text] [Related]
6. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
[TBL] [Abstract][Full Text] [Related]
7. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
9. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
10. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
[TBL] [Abstract][Full Text] [Related]
11. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
14. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
15. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
18. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.
Zaragoza E; Akolekar R; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):382-6. PubMed ID: 19277983
[TBL] [Abstract][Full Text] [Related]
20. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
